Literature DB >> 29696581

Potential biomarkers of tissue hypoxia during acute hemodilutional anemia in cardiac surgery: A prospective study to assess tissue hypoxia as a mechanism of organ injury.

Gregory M T Hare1,2,3,4, Kaho Han5, Yevheniy Leshchyshyn5, Nikhil Mistry5, Tiffanie Kei5, Si Yuan Dai5, Albert K Y Tsui5, Razak A Pirani5, Jaideep Honavar6, Rakesh P Patel6, Sanjay Yagnik5, Shelley L Welker7, Tessa Tam7, Alexander Romaschin8, Philip W Connelly9,8,10, W Scott Beattie11, C David Mazer5,12,13,9.   

Abstract

PURPOSE: Hemodilutional anemia is associated with acute kidney injury (AKI) and mortality in patients undergoing cardiac surgery by mechanisms that may include tissue hypoxia. Our hypothesis was to assess if changes in the potential hypoxic biomarkers, including methemoglobin and erythropoietin, correlated with a decrease in hemoglobin (Hb) concentration following hemodilution on cardiopulmonary bypass (CPB).
METHODS: Arterial blood samples were taken from patients (n = 64) undergoing heart surgery and CPB at baseline, during CPB, following CPB, and in the intensive care unit (ICU). Potential hypoxic biomarkers were measured, including methemoglobin, plasma Hb, and erythropoietin. Data were analyzed by repeated measures one-way analysis of variance on ranks and linear regression.
RESULTS: Hemoglobin levels decreased following CPB and methemoglobin increased in the ICU (P < 0.001 for both). No correlation was observed between the change in Hb and methemoglobin (P = 0.23). By contrast, reduced Hb on CPB correlated with increased lactate, reduced pH, and increased erythropoietin levels following CPB (P ≤ 0.004 for all). Increased plasma Hb (P < 0.001) also correlated with plasma erythropoietin levels (P < 0.001).
CONCLUSION: These data support the hypothesis that erythropoietin rather than methemoglobin is a potential biomarker of anemia-induced tissue hypoxia. The observed relationships between decreased Hb during CPB and the increase in lactate, reduced pH, and increase in erythropoietin levels suggest that early changes in plasma erythropoietin may be a pragmatic early biomarker of anemia-induced renal hypoxia. Further study is required to determine if anemia-induced increases in erythropoietin may predict AKI in patients undergoing cardiac surgery. TRIAL REGISTRATION: www.clinicaltrials.gov (NCT01883713). Registered 21 June 2013.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29696581     DOI: 10.1007/s12630-018-1140-0

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  4 in total

1.  Renal microvascular oxygen tension during hyperoxia and acute hemodilution assessed by phosphorescence quenching and excitation with blue and red light.

Authors:  Kyle Chin; Melina P Cazorla-Bak; Elaine Liu; Linda Nghiem; Yanling Zhang; Julie Yu; David F Wilson; Sergei A Vinogradov; Richard E Gilbert; Kim A Connelly; Roger G Evans; Andrew J Baker; C David Mazer; Gregory M T Hare
Journal:  Can J Anaesth       Date:  2020-11-10       Impact factor: 5.063

2.  Renal hemodynamics and oxygenation during experimental cardiopulmonary bypass in sheep under total intravenous anesthesia.

Authors:  Roger G Evans; Naoya Iguchi; Andrew D Cochrane; Bruno Marino; Sally G Hood; Rinaldo Bellomo; Peter R McCall; Clive N May; Yugeesh R Lankadeva
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-12-11       Impact factor: 3.619

3.  Alterations in Fetal Doppler Parameters Before and Twenty-Four Hours After Radiofrequency Ablation for Twin Reversed Arterial Perfusion Sequence.

Authors:  Lan Zhang; Hongli Liu; Shuai Huang; Chao Tong; Zhigang Wang; Hongbo Qi; Philip N Baker; Mark D Kilby
Journal:  Front Med (Lausanne)       Date:  2022-04-14

Review 4.  When to transfuse your acute care patient? A narrative review of the risk of anemia and red blood cell transfusion based on clinical trial outcomes.

Authors:  Gregory M T Hare; Melina P Cazorla-Bak; S F Michelle Ku; Kyle Chin; Nikhil Mistry; Michael C Sklar; Katerina Pavenski; Ahmad Alli; Adriaan Van Rensburg; Jan O Friedrich; Andrew J Baker; C David Mazer
Journal:  Can J Anaesth       Date:  2020-08-07       Impact factor: 6.713

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.